Real-time enrollment status for this relapsed hepatoblastoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:37 AM UTC
| NCT Number | NCT05556642 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Hepatoblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Last Updated on CT.gov | March 18, 2026 (Mar 18, 2026) |
As of July 18, 2026: Clinical trial NCT05556642 is currently recruiting participants. This clinical trial study for relapsed hepatoblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Children's Hospital Medical Center, Cincinnati. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05556642 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05556642 was last updated Mar 18, 2026 (March 18, 2026). HelloStudys verifies this status automatically.